文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 中医中药 > Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor
侵权投诉

Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor

Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor

ARTICLE

Received29Dec2013|Accepted1Dec2014|Published23Jan2015

DOI:10.1038/ncomms6988

OPEN

Gd-metallofullerenolnanomaterialasnon-toxicbreastcancerstemcell-speci cinhibitor

YingLiu1,*,ChunyingChen1,*,PengxuQian2,*,XuefeiLu2,BaoyunSun1,XiaoZhang2,LimingWang1,

XingfaGao1,HanLi1,ZhiyunChen1,JinglongTang1,WeijieZhang2,JinquanDong1,RuBai1,PeterE.Lobie2,3,QingfaWu2,SulingLiu2,HuafengZhang2,FengZhao1,MaxS.Wicha4,TaoZhu2&YuliangZhao1

Thecontemporaryuseofnanomedicinesforcancertreatmenthasbeenlargelylimitedtoservingascarriersforexistingtherapeuticagents.Here,weprovidede nitiveevidencethat,themetallofullerenolnanomaterialGd@C82(OH)22,whileessentiallynottoxictonormalmammaryepithelialcells,possessesintrinsicinhibitoryactivityagainsttriple-negativebreastcancercells.Gd@C82(OH)22blocksepithelial-to-mesenchymaltransitionwithresultantef cienteliminationofbreastcancerstemcells(CSCs)resultinginabrogationoftumourinitiationandmetastasis.Innormoxicconditions,Gd@C82(OH)22mediatestheseeffectsbyblockingTGF-bsignalling.Moreover,underhypoxicconditionsfoundinthetumourmicro-environment,cellularuptakeofGd@C82(OH)22isfacilitatedwhereitfunctionsasabi-potentinhibitorofHIF-1aandTGF-bactivities,enhancingCSCelimination.ThesestudiesindicatethatnanomaterialscanbeengineeredtodirectlytargetCSCs.Thus,Gd-metallofullerenolisidenti edasakindofnon-toxicCSCspeci cinhibitorswithsigni canttherapeuticpotential.

1CASKeyLaboratoryforBiomedicalEffectsofNanomaterialsandNanosafety,NationalCenterforNanoscienceandTechnologyofChinaandInstituteofHigh

EnergyPhysics,ChineseAcademyofSciences(CAS),Beijing100190,China.2HefeiNationalLaboratoryforPhysicalSciencesatMicroscaleandSchoolofLifeSciences,UniversityofScienceandTechnologyofChina,Hefei,Anhui230027,China.3CancerScienceInstituteofSingaporeandDepartmentofPharmacology,NationalUniversityofSingapore,Singapore117456,Singapore.4ComprehensiveCancerCenter,DepartmentofInternalMedicine,UniversityofMichigan,AnnArbor,Michigan48109,USA.*Theseauthorscontributedequallytothiswork.CorrespondenceandrequestsformaterialsshouldbeaddressedtoT.Z.(email:zhut@ustc.edu.cn)ortoY.Z.(email:zhaoyuliang@ihep.ac.cn).

NATURECOMMUNICATIONS|6:5988|DOI:10.1038/ncomms6988|doc.guandang.net

1

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email